INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

An expert overview of the literature, useful as background reading.

519 studies · page 9 of 22

2016 / Document analysis of clinical study reports, protocols, and publications

Analysis of orlistat trials found that published papers reported only 3% to 33% of investigator-reported adverse events due to post hoc filters.

Researchers analyzed 8,716 pages of clinical study reports (CSRs) and protocols from seven randomized placebo-controlled trials of orlistat (4,225 participants) and compared them with published papers. Only 3% to 33% of investigator-reported adverse events appeared in publications due to post hoc filters, despite six of seven papers claiming all adverse events were recorded. In one trial, orlistat-treated participants experienced significantly more days with adverse events than placebo (22.7 d vs. 14.9 d, p < 0.0001) and more severe events, details omitted from CSRs and publications. A key limitation is that the analysis was restricted to one drug tested in the mid-1990s, which may not apply to newer drugs.

Schroll JB, Penninga EI, Gøtzsche PC PLoS Med, 2016. PMID 27529343

2016 / Narrative review

Disturbances in sleep and circadian rhythms are linked to increased risk of weight gain and altered food choices.

This review summarizes recent findings linking sleep and circadian rhythm disturbances to an increased risk of obesity. Sleep and circadian disruptions adversely affect food choices, hunger, appetite, and energy balance, and are associated with lifelong metabolic consequences when occurring in childhood or early adulthood. Upregulation of the endocannabinoid system, altered temporal distribution of caloric intake, and changes in the gut microbiome were identified as potential mechanisms linking sleep loss and circadian misalignment to obesity. Manipulations of the timing of food intake are suggested as potential preventive countermeasures.

Shows an association, not proof of cause and effect.

Broussard JL, Van Cauter E Curr Opin Endocrinol Diabetes Obes, 2016. PMID 27584008

2016 / Scientific statement / narrative review

Short sleep duration and sleep disorders are related to adverse cardiometabolic risks such as obesity, hypertension, type 2 diabetes, and cardiovascular disease.

This American Heart Association scientific statement reviews evidence linking sleep duration and sleep disorders to cardiometabolic health. It notes a decline in average sleep duration among Americans due to curtailing sleep for work, social, or leisure activities. Sleep duration, particularly short sleep, and sleep disorders have emerged as related to adverse cardiometabolic risks, including obesity, hypertension, type 2 diabetes mellitus, and cardiovascular disease. The authors call for health organizations to incorporate evidence-based sleep recommendations into guidelines for optimal health.

Shows an association, not proof of cause and effect.

St-Onge MP, Grandner MA, Brown D, et al. Circulation, 2016. PMID 27647451

2016 / Narrative review

Pharmacotherapies and food components like thylakoids show potential for targeting reward-induced eating and food cravings.

This narrative review examines appetite and reward-induced eating behavior, noting that cravings triggered by food cues activate mesocorticolimbic dopamine pathways and affect weight outcomes. Approved weight-management medications, including naltrexone-bupropion, lorcaserin, liraglutide, and phentermine, show promise or preliminary efficacy in targeting craving-related eating behavior. Additionally, food components such as thylakoid membranes have been shown to influence food cravings.

Rebello CJ, Greenway FL Adv Ther, 2016. PMID 27718159

2016 / Narrative review

A review notes that epidemiological research consistently links most fruits to anti-obesity effects despite their sugar content.

This review analyzes the paradoxical relationships and possible mechanisms between fruit intake and anti-obesity effects, addressing why fruits with simple sugars often aid rather than hinder weight reduction. The authors note that health organizations suggest consuming fruit for weight reduction due to its anti-obesity effects and micronutrient content. The review concludes that different types of fruit exert different effects on human body weight.

Shows an association, not proof of cause and effect.

Sharma SP, Chung HJ, Kim HJ, et al. Nutrients, 2016. PMID 27754404

2016 / Position statement

Appropriately planned vegetarian and vegan diets are healthful, nutritionally adequate, and linked to reduced risks of certain chronic diseases.

The Academy of Nutrition and Dietetics states that appropriately planned vegetarian, including vegan, diets are healthful, nutritionally adequate, and appropriate for all stages of the life cycle and athletes. Vegetarians and vegans have a reduced risk of conditions such as ischemic heart disease, type 2 diabetes, hypertension, certain cancers, and obesity. Diets low in saturated fat and high in vegetables, fruits, whole grains, legumes, soy, nuts, and seeds yield lower total and LDL cholesterol and improved glucose control. The position statement notes that vegans require reliable sources of vitamin B-12 from fortified foods or supplements.

Melina V, Craig W, Levin S J Acad Nutr Diet, 2016. PMID 27886704

2016 / Narrative review / perspective

Authors propose using the terms 'overfat' and 'underfat' to better describe body composition states linked to metabolic health impairments.

The authors discuss that the number of obese people worldwide exceeds those who are underweight, arguing that an 'overfat' pandemic exists involving excess fat mass relative to lean mass that may not be captured by body mass index. Concurrently, the 'underfat' state remains a dangerous circumstance linked to chronic illness and starvation. The article contends that adopting 'overfat' and 'underfat' into common usage may raise awareness and aid prevention and remediation efforts.

Maffetone PB, Rivera-Dominguez I, Laursen PB Front Public Health, 2016. PMID 28097119

2016 / Narrative review

Substantial weight loss from calorie restriction can reverse type 2 diabetes by normalizing liver fat, pancreatic fat, and first-phase insulin secretion.

This review examines how calorie restriction impacts the pathophysiology of type 2 diabetes. Negative calorie balance decreases liver fat within days, restoring normal hepatic glucose production control. Over 8 weeks, it allows intra-pancreatic fat levels and first-phase insulin secretion to normalize, supporting the Twin Cycle Hypothesis. The author notes type 2 diabetes can be understood as an excess fat state in the liver and pancreas, remaining reversible for at least 10 years in most individuals.

Taylor R Expert Rev Endocrinol Metab, 2016. PMID 30058916

2016 / Narrative review

Daily physical activity and structured exercise generally produce beneficial effects on body weight without offsetting compensatory responses.

This narrative review evaluated scientific literature regarding the role of physical activity in body weight regulation and energy balance. Based on the existing literature, daily physical activity and structured exercise in adequate amounts increased total daily energy expenditure and created an acute energy deficit. In most instances, this occurred without compensatory declines in non-exercise physical activity or energy expenditure, and without compensatory increases in energy intake. The authors noted gaps in the literature, including a lack of adequately powered clinical trials with rigorous assessments of energy intake and expenditure across diverse populations, volumes, and intensities.

Shook RP Expert Rev Endocrinol Metab, 2016. PMID 30058919

2015 / Narrative review

Higher adiposity was associated with frontal gray matter atrophy across all ages, and parietal and temporal atrophy in middle-aged and older adults.

This review evaluated studies assessing obesity and gray or white matter volumes globally or in specific regions of interest. Across all ages, higher adiposity was consistently associated with frontal gray matter atrophy, particularly in the prefrontal cortex. In children and adults under 40 years of age, most studies found no link with occipital or parietal gray matter volumes, while temporal lobe results were mixed. In middle-aged and older adults, higher adiposity was linked to parietal and temporal gray matter atrophy, while findings for the precuneus, posterior cingulate, and hippocampus were mixed. No clear association was observed with global or regional white matter in any age group.

Shows an association, not proof of cause and effect.

Willette AA, Kapogiannis D Ageing Res Rev, 2015. PMID 24768742

2015 / Narrative review

A review evaluates scientific evidence for 9 myths and 10 common presumptions surrounding obesity and weight loss.

This review evaluates 9 myths (strongly held beliefs contradicted by scientific evidence) and 10 presumptions (beliefs lacking scientific evidence to support them) in obesity research. The authors examine topics including rapid weight loss, realistic goals, physical education, breastfeeding, breakfast consumption, fruit and vegetable intake, snacking, portion size, and drinking water. For each topic, the paper details evidence directly supporting or refuting the belief, incorporating findings from randomized controlled trials when available, and provides suggestions to limit the spread of unsubstantiated beliefs.

Casazza K, Brown A, Astrup A, et al. Crit Rev Food Sci Nutr, 2015. PMID 24950157

2015 / Narrative review

Lifestyle modifications are effective in improving or restoring erectile function in individuals with obesity or metabolic syndrome.

This review evaluated modifiable risk factors for erectile dysfunction (ED), including diet, physical activity, smoking, alcohol use, and excess weight. These factors are linked to a pro-inflammatory state that contributes to endothelial dysfunction by reducing nitric oxide availability. In clinical trials, lifestyle changes were reported to ameliorate ED or restore absent ED in individuals with obesity or metabolic syndrome.

Maiorino MI, Bellastella G, Esposito K Asian J Androl, 2015. PMID 25248655

2015 / Narrative review

A review discusses subpopulations where obesity may not be harmful or where weight loss might not always improve health.

This review takes a devil's advocate position to discuss subgroups of obese individuals who may not be adversely affected by their weight, or who may even benefit from higher adiposity. It examines situations where weight loss per se may not be the most appropriate recommendation. Specifically, it addresses adults with established cardiovascular disease, type 2 diabetes, weight cyclers, metabolically healthy obese adults, youth, older adults, and highly fit obese individuals.

Brown RE, Kuk JL Obes Rev, 2015. PMID 25410935

2015 / Narrative review

The obesity epidemic is associated with increased cancer incidence and may lead to poor cancer outcomes via metabolic and signaling pathways.

This review examines the relationship between the obesity epidemic and cancer incidence and outcomes. Obesity is associated with increased cancer incidence at a population level and may lead to poor cancer outcomes, though concurrent decreases in overall cancer mortality may reflect improvements in diagnosis and treatment. Biologically, active adipose tissue secretes estrogens, adipokines, and cytokines, and adipose reprogramming may lead to insulin resistance, impacting cancer progression locally, systemically, through pathways such as PI3K and JAK-STAT, or via the tumor microenvironment.

Shows an association, not proof of cause and effect.

Goodwin PJ, Stambolic V Annu Rev Med, 2015. PMID 25423596

2015 / Narrative review

A review indicates inflamed adipose tissue and dyslipidemia play pivotal roles beyond joint loading in obesity-induced osteoarthritis.

This review examines the mechanisms linking obesity to osteoarthritis. It evaluates the historical view of altered joint loading and wear and tear alongside the impact of disturbed lipid metabolism, low-grade inflammation, and adipokines on joint tissues. The authors conclude that inflamed adipose tissue and dyslipidemia play key roles in obesity-induced osteoarthritis, extending beyond excessive mechanical loading.

Thijssen E, van Caam A, van der Kraan PM Rheumatology (Oxford), 2015. PMID 25504962

2015 / Hypothesis / narrative review

The personal fat threshold hypothesis proposes that exceeding an individual fat capacity triggers type 2 diabetes independently of BMI.

Authors present the personal fat threshold (PFT) hypothesis to explain type 2 diabetes (T2DM) occurrence in normal-BMI individuals. Data from the UKPDS cohort of individuals diagnosed in the 1970s and 1980s showed a median BMI of 28 kg/m2, with one in three having a BMI under 25 kg/m2. The authors hypothesize that exceeding one's individual PFT triggers T2DM, and subsequent weight loss below this threshold permits return to normal glucose control regardless of whether the person is classified as obese by BMI.

Taylor R, Holman RR Clin Sci (Lond), 2015. PMID 25515001

2015 / Systematic literature review

Regular self-weighing was linked to greater weight loss without adverse psychological outcomes in adults seeking weight loss.

A systematic review of 17 prospective, longitudinal studies evaluated the relationships between regular self-weighing, weight change, and psychological outcomes in adults seeking weight loss. Regular self-weighing was associated with more weight loss and was not associated with adverse psychological outcomes such as depression or anxiety. The effect sizes of the association between self-weighing and weight change varied across studies, as did the reported frequency of self-weighing.

Shows an association, not proof of cause and effect.

Zheng Y, Klem ML, Sereika SM, et al. Obesity (Silver Spring), 2015. PMID 25521523

2015 / Critical narrative review

There is very little clinical evidence and no randomized controlled trials supporting commercial detox diets for toxin elimination or weight management.

This review examined the necessity, components, efficacy, and potential dangers of detox diets. Very little clinical evidence supports these diets; a few clinical studies reported that commercial detox diets enhance liver detoxification and eliminate persistent organic pollutants, but were hampered by small sample sizes and flawed methodologies. No randomised controlled trials have assessed commercial detox diets in humans, and evidence for specific foods (such as coriander, nori, and olestra) is primarily from animal studies.

Klein AV, Kiat H J Hum Nutr Diet, 2015. PMID 25522674

2015 / Editorial

An editorial outlines several reasons why anti-obesity pharmacological treatments remain stigmatized.

This editorial discusses why anti-obesity medications are stigmatized despite being useful tools alongside lifestyle modifications. Identified reasons include the failure of short-term medication use to achieve long-term results, the common perception of obesity as a lifestyle choice, and difficulties treating obesity in primary care. Additional factors cited are less than desired weight-loss results, misuse of medications for cosmetic reasons, and an unfavorable history of other anti-obesity drugs withdrawn in previous decades.

Halpern B, Halpern A Expert Opin Drug Saf, 2015. PMID 25529104

2015 / Narrative review

Intermittent and alternate-day fasting show potential for promoting weight loss, though hunger may be a limiting factor for long-term adherence.

This review evaluates whether fasting regimens, such as alternate-day fasting or the 5:2 diet, represent effective strategies or short-term dieting trends for obesity management. Intermittent fasting approaches appear to promote weight loss without complex daily calorie counting, but they are linked to hunger, which can hinder ongoing dietary restriction. The long-term effects of chronic food restriction in humans remain unclear, and no single dietary intervention will solve the obesity epidemic.

Johnstone A Int J Obes (Lond), 2015. PMID 25540982

2015 / Narrative review

Clinical trials examining the metabolic effects of resveratrol have yielded mixed results.

This review evaluates the metabolic effects and mechanism of action of resveratrol, a polyphenol found in plant-based foods such as red wine. Resveratrol has been reported to have diverse healthful effects, including improving mitochondrial function and protecting against obesity, type-2 diabetes, cardiovascular dysfunction, and cancer cell growth. However, clinical trials investigating its metabolic effects have produced mixed results, leaving several controversies unresolved.

Bitterman JL, Chung JH Cell Mol Life Sci, 2015. PMID 25548801

2015 / Clinical practice guideline with systematic reviews

Approved weight-loss medications are useful adjuncts to lifestyle changes for patients unsuccessful with diet and exercise alone, according to guidelines.

An Endocrine Society-appointed Task Force developed evidence-based clinical practice guidelines for the pharmacological management of obesity using the GRADE system and two systematic reviews. The guidelines concluded that medications approved for chronic weight management serve as useful adjuncts to lifestyle changes for patients who have been unsuccessful with diet and exercise alone. Furthermore, because many drugs prescribed for conditions such as diabetes and depression impact weight, prescribing medications with favorable weight profiles can aid obesity prevention and management.

Apovian CM, Aronne LJ, Bessesen DH, et al. J Clin Endocrinol Metab, 2015. PMID 25590212

2015 / Roundtable discussion summary report

A roundtable discussion highlighted that current candy intake levels are not associated with weight gain or cardiovascular disease risk in children and adults.

A roundtable of behavioral nutrition experts, researchers, and nutrition educators reviewed candy consumption patterns, related health outcomes, and behavioral strategies to promote moderation. Although 97% of Americans report eating candy at least once yearly, only about one-fourth of the US population aged ≥2 years consumes it on a given day, contributing a relatively small proportion of calories, added sugars, and saturated fat. Recent research cited suggests current candy consumption levels are not associated with weight gain or cardiovascular disease risk in children and adults. The panel noted that restricting access to palatable foods may have negative consequences and identified behavioral and environmental strategies as key steps to promote moderation.

Shows an association, not proof of cause and effect.

Duyff RL, Birch LL, Byrd-Bredbenner C, et al. Adv Nutr, 2015. PMID 25593156

2015 / Narrative review

Obesity was linked to a loss of white matter integrity, showing inverse associations between BMI and fractional anisotropy across various brain tracts.

This review evaluated the relationship between obesity and brain alterations assessed by diffusion tensor imaging (DTI). Altogether, reviewed studies demonstrated a loss of white matter integrity with obesity-related factors, particularly in tracts within the limbic system and those connecting the temporal and frontal lobes. Multiple studies found an inverse association between BMI and fractional anisotropy in the corpus callosum, fornix, cingulum, and corona radiata in elderly, young adults, and children. In addition, significant interactions between BMI and age suggested accelerated aging of white matter structure in obesity.

Shows an association, not proof of cause and effect.

Kullmann S, Schweizer F, Veit R, et al. Obes Rev, 2015. PMID 25676886